Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, Pennsylvania, USA.
Department of Cardiothoracic Surgery, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania, USA.
J Card Surg. 2022 Jun;37(6):1691-1704. doi: 10.1111/jocs.16431. Epub 2022 Mar 27.
Transcatheter mitral valve implantation (TMVI) has emerged as a less invasive approach potentially surmounting some of the current hurdles associated with transcatheter edge-to-edge repair and high-risk mitral valve surgery. In this review, we aimed to outline the main scenarios in the TMVI field, highlight current and upcoming devices, and describe challenges and clinical results. Finally, we briefly discuss the future perspectives for this emerging field and how TMVI might further advance the field of transcatheter treatments of mitral valve disease.
经导管二尖瓣植入术 (TMVI) 作为一种微创方法,有可能克服经导管缘对缘修复术和高危二尖瓣手术目前面临的一些难题。本文旨在概述 TMVI 领域的主要方案,重点介绍当前和即将推出的器械,并描述相关挑战和临床结果。最后,我们简要讨论这一新兴领域的未来前景,以及 TMVI 如何进一步推动二尖瓣疾病的经导管治疗领域的发展。